Beta-Amyloid (1-37)

Overview

Beta-Amyloid (1-37) is a pivotal component in the study of Alzheimer’s disease and related neurodegenerative conditions. This minor Beta-Amyloid peptide is produced in the brain, contributing to the complex framework of amyloid deposits typically found in patients with Alzheimer’s. While much attention is given to the more common variants like Aβ1-40 and Aβ1-42, Beta-Amyloid (1-37) remains an essential focus for researchers eager to understand its role in various physiological and pathological processes.

Key Features

• High purity, ideal for research applications
• Contributes to a better understanding of Alzheimer’s pathology
• Supports accurate quantification and analysis of amyloid peptides
• Available in convenient vial sizes for laboratory use
• Backed by our commitment to quality in peptide production

Specifications

FAQ

What is Beta-Amyloid (1-37)?

Beta-Amyloid (1-37) is a shorter form of the Beta-Amyloid peptide that plays a role in the formation of amyloid plaques in the brain, influencing research into Alzheimer’s disease.

How is Beta-Amyloid (1-37) used in research?

This peptide is essential for understanding the dynamics of amyloid formation and its effects on neurological health, particularly in Alzheimer’s research.

What are the storage requirements for this peptide?

Beta-Amyloid (1-37) should be stored at -20°C to maintain its integrity and effectiveness for your research.

If you are investigating the intricacies of Alzheimer’s pathology, consider adding Beta-Amyloid (1-37) to your research toolkit. Enhance your studies with this critical peptide, which lays the groundwork for deeper insights into neurodegenerative diseases. You can explore our full range of peptides for various research applications by visiting our catalog.

Related Products

• PKG Substrate [RKRSRAE], Glasstide
• Autocamtide-2 [KKALRRQETVDAL]
• CREBtide [KRREILSRRPSYR], 5-FAM labeled

Browse more in Peptides.